BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9519908)

  • 1. Beta-lactamase production and the role of ampicillin/sulbactam.
    Alpuche-Aranda CM
    Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S8-11; discussion S20-1. PubMed ID: 9519908
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use of sultamicillin (ampicillin/sulbactam) in children.
    López EL; Rivas NA
    Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S12-4; discussion S20-1. PubMed ID: 9519909
    [No Abstract]   [Full Text] [Related]  

  • 3. Ampicillin-sulbactam and ticarcillin-clavulanic acid: a comparison of their in vitro activity and review of their clinical efficacy.
    Itokazu GS; Danziger LH
    Pharmacotherapy; 1991; 11(5):382-414. PubMed ID: 1745624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ampicillin-sulbactam.
    Dajani AS
    Pediatr Ann; 1993 Mar; 22(3):197-200. PubMed ID: 8464651
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current role of penicillin antibiotics: focused on sulbactam sodium/ampicillin sodium. Discussion].
    Jpn J Antibiot; 1994 Nov; 47(11):1421-32. PubMed ID: 7853672
    [No Abstract]   [Full Text] [Related]  

  • 7. Activity of ampicillin plus sulbactam against beta-lactamase producing enterococci in experimental endocarditis.
    Thal LA; Vazquez J; Perri MB; Beckley A; Donabedian S; Kaatz GW; Patterson JE; Zervos MJ
    J Antimicrob Chemother; 1993 Jan; 31(1):182-5. PubMed ID: 8444668
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of ampicillin/sulbactam plus aminoglycoside vs. ampicillin plus clindamycin plus aminoglycoside in the treatment of intraabdominal infections in children. The Multicenter Group.
    Collins MD; Dajani AS; Kim KS; King DR; Kaplan SL; Azimi PH; Kolokathis A; Swanson R
    Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S15-8; discussion S20-1. PubMed ID: 9519910
    [No Abstract]   [Full Text] [Related]  

  • 9. Ampicillin/sulbactam--a combination of an old and a new agent in the treatment of infection.
    Kerins DM
    Am J Med Sci; 1991 Jun; 301(6):406-11. PubMed ID: 2039029
    [No Abstract]   [Full Text] [Related]  

  • 10. [In vitro activity of ampicillin and ampicillin-sulbactam on diverse bacteria].
    Trucco O; Prado V; Mollinedo E; Cordoves A
    Rev Med Chil; 1989 Jul; 117(7):747-54. PubMed ID: 2519428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of ampicillin/sulbactam (sultamicillin) in the management of pediatric infections. Introduction.
    Arredondo-García JL
    Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S3. PubMed ID: 9519906
    [No Abstract]   [Full Text] [Related]  

  • 12. Ampicillin/sulbactam: current status in severe bacterial infections.
    Rafailidis PI; Ioannidou EN; Falagas ME
    Drugs; 2007; 67(13):1829-49. PubMed ID: 17722953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections.
    Akova M; Ozcebe O; Güllü I; Unal S; Gür D; Akalin S; Tokgözoglu M; Telatar F; Akalin HE
    J Chemother; 1996 Aug; 8(4):284-9. PubMed ID: 8873834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences with sultamicillin granules in pediatric patients].
    Iguchi K; Kamiya H; Sakurai M; Shimizu S; Nishi H; Kawaguchi H; Yoshizumi T; Inoue M; Kojima M
    Jpn J Antibiot; 1988 Dec; 41(12):1906-13. PubMed ID: 3249363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of clavulanic acid sulbactam on induction of class 1 beta-lactamase.
    Farmer TH; Reading C
    J Chemother; 1989 Jul; 1(4 Suppl):331-3. PubMed ID: 16312426
    [No Abstract]   [Full Text] [Related]  

  • 16. Worldwide clinical experience with sultamicillin.
    Pitts NE; Gilbert GS; Knirsch AK; Noguchi Y
    APMIS Suppl; 1989; 5():23-34. PubMed ID: 2660868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of sultamicillin fine granules in pediatric infections].
    Meguro H; Arimasu O; Hiruma F; Sugie N; Nishimura S; Abe T; Fujii R; Mashiko J; Nagao Y; Okamoto Y
    Jpn J Antibiot; 1988 Dec; 41(12):1847-54. PubMed ID: 3249358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experience with sulbactam/ampicillin in the pediatric field].
    Sekiguchi T; Okamoto T; Ohara K; Kohzan S; Nishimori M; Miyazaki M
    Jpn J Antibiot; 1989 Mar; 42(3):733-42. PubMed ID: 2746853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of the sulbactam-ampicillin combination.
    Sessarego FV; Botta GA; Pesce A; Schito GC
    J Chemother; 1989 Dec; 1(6):384-7. PubMed ID: 2614505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.